Indications
Indicated for the improvement of moderate to severe fatigue caused by disease progression in patients with terminal cancer
Main Ingredients
The active fraction of Astragalus polysaccharides obtained by extraction, separation, and purification from the traditional Chinese medicine Huang Qi (Astragalus). Each vial contains 500mg of Polysaccharides of Astragalus membranaceus extract.
License Number
MOHW Drug Manufacturing License No. 058837 (衛部藥製字第058837號)
